Self-assembled copper-amino acid nanoleaves for targeted treatment of deep-seated bacterial infections via chemodynamic therapy and cuproptosis-like death
Yutong Li , Yuhang Li , Haojie Chen , Yongcheng Chen , Yanwen Ni , Jian Ji , Kaijun Wang , Qiao Jin
{"title":"Self-assembled copper-amino acid nanoleaves for targeted treatment of deep-seated bacterial infections via chemodynamic therapy and cuproptosis-like death","authors":"Yutong Li , Yuhang Li , Haojie Chen , Yongcheng Chen , Yanwen Ni , Jian Ji , Kaijun Wang , Qiao Jin","doi":"10.1016/j.biomaterials.2025.123566","DOIUrl":null,"url":null,"abstract":"<div><div>Transition metal ions such as Cu<sup>2+</sup> are promising broad-spectrum bactericidal agents. However, transition metal ions are not used to treat deep-seated bacterial infections in clinic owing to easy deactivation by proteins and lack of targeting ability. Herein, hyaluronic acid (HA)-modified copper-N-acetyl-<span>l</span>-cysteine (NAC) nanoleaves (CNH NLs) are developed to treat deep-seated bacterial infections by targeted delivery of Cu<sup>2+</sup> to infection sites. Cu-NAC nanoleaves (CN NLs) can be synthesized by coordinate assembly of Cu<sup>2+</sup> and NAC, which are further coated with HA to obtained CNH NLs with targeting ability. CNH NLs are stable in neutral physiological environment, while can be easily decomposed in acidic infection sites, leading to rapid release of Cu<sup>2+</sup>. The released Cu<sup>2+</sup> disrupts bacterial membranes, depletes glutathione, generates reactive oxygen species (ROS), and induces cuproptosis-like bacterial death, exhibiting potent activity against both planktonic bacteria and biofilms. The targeted accumulation and excellent therapeutic efficacy of CNH NLs is further confirmed on murine bacterial keratitis and pneumonia models, highlighting their therapeutic potential for deep-seated infections.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"325 ","pages":"Article 123566"},"PeriodicalIF":12.9000,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0142961225004855","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Transition metal ions such as Cu2+ are promising broad-spectrum bactericidal agents. However, transition metal ions are not used to treat deep-seated bacterial infections in clinic owing to easy deactivation by proteins and lack of targeting ability. Herein, hyaluronic acid (HA)-modified copper-N-acetyl-l-cysteine (NAC) nanoleaves (CNH NLs) are developed to treat deep-seated bacterial infections by targeted delivery of Cu2+ to infection sites. Cu-NAC nanoleaves (CN NLs) can be synthesized by coordinate assembly of Cu2+ and NAC, which are further coated with HA to obtained CNH NLs with targeting ability. CNH NLs are stable in neutral physiological environment, while can be easily decomposed in acidic infection sites, leading to rapid release of Cu2+. The released Cu2+ disrupts bacterial membranes, depletes glutathione, generates reactive oxygen species (ROS), and induces cuproptosis-like bacterial death, exhibiting potent activity against both planktonic bacteria and biofilms. The targeted accumulation and excellent therapeutic efficacy of CNH NLs is further confirmed on murine bacterial keratitis and pneumonia models, highlighting their therapeutic potential for deep-seated infections.
期刊介绍:
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.